These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33422676)

  • 61. Biologically produced and metal-organic framework delivered dual-cut CRISPR/Cas9 system for efficient gene editing and sensitized cancer therapy.
    Yu J; Tang M; Zhou Z; Wei Z; Wan F; Hou S; Li Q; Li Y; Tian L
    Acta Biomater; 2024 Apr; 178():296-306. PubMed ID: 38417646
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
    Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
    [TBL] [Abstract][Full Text] [Related]  

  • 64. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
    Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
    Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct.
    Kim S; Jeong YK; Cho CS; Lee S; Sohn CH; Kim JH; Jeong Y; Jo DH; Bae S; Lee H
    Adv Healthc Mater; 2023 Feb; 12(4):e2201825. PubMed ID: 36326169
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interrogation of human microglial phagocytosis by CRISPR genome editing.
    Chang JC; Wang CY; Lin S
    Front Immunol; 2023; 14():1169725. PubMed ID: 37483607
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inducible Genome Editing with Conditional CRISPR/Cas9 Mice.
    Katigbak A; Robert F; Paquet M; Pelletier J
    G3 (Bethesda); 2018 May; 8(5):1627-1635. PubMed ID: 29519936
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ex Vivo Expansion and CRISPR-Cas9 Genome Editing of Primary Human Natural Killer Cells.
    Huang RS; Lai MC; Lin S
    Curr Protoc; 2021 Sep; 1(9):e246. PubMed ID: 34529358
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A quaternary ammonium-based nanosystem enables delivery of CRISPR/Cas9 for cancer therapy.
    Zhang M; Sun S; Liang X; Liu Z; Yin J; Li Q; Yang S
    Biomater Sci; 2024 Feb; 12(5):1197-1210. PubMed ID: 38240497
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genome editing in
    Sinha T; Yazdani SS
    STAR Protoc; 2022 Sep; 3(3):101629. PubMed ID: 36042883
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Non-viral delivery of the CRISPR/Cas system: DNA
    Lin Y; Wagner E; Lächelt U
    Biomater Sci; 2022 Mar; 10(5):1166-1192. PubMed ID: 35103261
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies.
    Graham S; Gao L; Wang R
    J Vis Exp; 2021 Jun; (172):. PubMed ID: 34152311
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rapid and efficient cataract gene evaluation in F0 zebrafish using CRISPR-Cas9 ribonucleoprotein complexes.
    Zhao D; Jones JL; Gasperini RJ; Charlesworth JC; Liu GS; Burdon KP
    Methods; 2021 Oct; 194():37-47. PubMed ID: 33418061
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genome Engineering of Hematopoietic Stem Cells Using CRISPR/Cas9 System.
    Devaraju N; Rajendiran V; Ravi NS; Mohankumar KM
    Methods Mol Biol; 2022; 2429():307-331. PubMed ID: 35507170
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 76. Analysis of conventional and alternative CRISPR/Cas9 genome editing to enhance a single-base pair knock-in mutation.
    Edmondson C; Zhou Q; Liu X
    BMC Biotechnol; 2021 Jul; 21(1):45. PubMed ID: 34315458
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing
    Hamada T; Yokoyama S; Akahane T; Matsuo K; Tanimoto A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613947
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemical Evolution of Amphiphilic Xenopeptides for Potentiated Cas9 Ribonucleoprotein Delivery.
    Lin Y; Luo X; Burghardt T; Dorrer S; Höhn M; Wagner E; Lächelt U
    J Am Chem Soc; 2023 Jul; 145(28):15171-15179. PubMed ID: 37395536
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Different Methods of Delivering CRISPR/Cas9 Into Cells.
    Chandrasekaran AP; Song M; Kim KS; Ramakrishna S
    Prog Mol Biol Transl Sci; 2018; 159():157-176. PubMed ID: 30340786
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34
    Cromer MK; Vaidyanathan S; Ryan DE; Curry B; Lucas AB; Camarena J; Kaushik M; Hay SR; Martin RM; Steinfeld I; Bak RO; Dever DP; Hendel A; Bruhn L; Porteus MH
    Mol Ther; 2018 Oct; 26(10):2431-2442. PubMed ID: 30005866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.